Abbreviation | ECNP |
---|---|
Formation | 1987 |
Type | Non-Profit Scientific Organization |
President
|
Celso Arango, Spain |
Key people
|
Celso Arango (president) Guy Goodwin (Past-President) Gitte Moos Knudsen (president-elect) Laurence Lanfumey (Vice-President) Martien Kas (secretary) Eduard Vieta (treasurer) |
Website | http://www.ecnp.eu |
The European College of Neuropsychopharmacology (ECNP) is a pan-European, non-profit scientific association that serves as a platform to exchange and promote research in the field of neuropsychopharmacology. The ECNP “is committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health”. The ECNP organizes a number of activities to achieve this aim, such as a yearly congress, schools, workshops, seminars and supported talks.
In 1984 representatives of neuropsychopharmacological societies from across Europe suggested there might be room for a European structure. A meeting to discuss this plan further was held in Copenhagen in May 1985. It was decided that a European College of Neuropsychopharmacology would be founded. A Working Group was formed to plan of the association’s inaugural scientific congress. This congress was held in Brussels in 1987. Around 500 people attended. The Working Group consisted of:
In 1993 the College established a permanent secretariat in Utrecht, Netherlands.
The ECNP’s executive organ is the Executive Committee. The Executive Committee consists of six officers (the president, vice- president, president-elect, past-president, secretary and treasurer) and a maximum of six councillors. The Executive Committee has a three year term.
The 2013-2016 Executive Committee consists of:
Celso Arango, Spain, president
Guy Goodwin, United Kingdom, Past-President
Gitte Moos Knudsen, Denmark, president-elect
Joseph Zohar, Israel, past-president
Laurence Lanfumey, France, Vice-President
Eduard Vieta, Spain, treasurer Martien Kas, The Netherlands, Secretary